BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mechanick JI, Farkouh ME, Newman JD, Garvey WT. Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;75:525-38. [PMID: 32029136 DOI: 10.1016/j.jacc.2019.11.044] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Zhao H, Wang J. Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities. Front Cardiovasc Med 2021;8:650278. [PMID: 34026868 DOI: 10.3389/fcvm.2021.650278] [Reference Citation Analysis]
2 Philip C, Seifried R, Peterson PG, Liotta R, Steel K, Bittencourt MS, Hulten EA. Cardiac MRI for Patients with Increased Cardiometabolic Risk. Radiol Cardiothorac Imaging 2021;3:e200575. [PMID: 33969314 DOI: 10.1148/ryct.2021200575] [Reference Citation Analysis]
3 Bakbak E, Terenzi DC, Trac JZ, Teoh H, Quan A, Glazer SA, Rotstein OD, Al-Omran M, Verma S, Hess DA. Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease? Rev Endocr Metab Disord 2021. [PMID: 34228302 DOI: 10.1007/s11154-021-09669-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gonzalez-Rivas JP, Mechanick JI, Infante-Garcia MM, Medina-Inojosa JR, Pavlovska I, Hlinomaz O, Zak P, Kunzova S, Nieto-Martinez R, Skladaná M, Brož J, Hernandez JP, Lopez-Jimenez F, Stokin GB. The Prevalence of Dysglycemia-Based Chronic Disease in a European Population - a New Paradigm to Address Diabetes Burden: A Kardiovize Study. Endocr Pract 2021;27:455-62. [PMID: 33685667 DOI: 10.1016/j.eprac.2020.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang X, Hu C, Wu HM, Ma ZG, Tang QZ. Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target. Acta Pharmacol Sin 2021;42:1390-400. [PMID: 33214697 DOI: 10.1038/s41401-020-00557-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pavlovska I, Polcrova A, Mechanick JI, Brož J, Infante-Garcia MM, Nieto-Martínez R, Maranhao Neto GA, Kunzova S, Skladana M, Novotny JS, Pikhart H, Urbanová J, Stokin GB, Medina-Inojosa JR, Vysoky R, González-Rivas JP. Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health. Nutrients 2021;13:2338. [PMID: 34371848 DOI: 10.3390/nu13072338] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Nadolsky KZ, Hurley DL, Garvey WT. Covid-19 & Obesity: Beyond Bmi. Endocr Pract 2020;26:923-5. [PMID: 33471684 DOI: 10.4158/EP-2020-0302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Garvey WT. New Horizons A New Paradigm for Treating to Target with Second-Generation Obesity Medications. J Clin Endocrinol Metab 2021:dgab848. [PMID: 34865050 DOI: 10.1210/clinem/dgab848] [Reference Citation Analysis]
9 Kaplan RM, Tanaka Y, Passman RS, Fine M, Rasmussen-Torvik LJ, Vupputuri S, Martin K, Khan SS. Efficacy and Safety of Direct Oral Anticoagulants for Atrial Fibrillation Across Body Mass Index Categories. J Am Heart Assoc 2020;9:e017383. [PMID: 33302751 DOI: 10.1161/JAHA.120.017383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Pavlovska I, Mechanick JI, Maranhao Neto GA, Infante-Garcia MM, Nieto-Martinez R, Kunzova S, Polcrova A, Vysoky R, Medina-Inojosa JR, Lopez-Jimenez F, Stokin GB, González-Rivas JP. Arterial Stiffness and Cardiometabolic-Based Chronic Disease: The Kardiovize Study. Endocr Pract 2021;27:571-8. [PMID: 33722731 DOI: 10.1016/j.eprac.2021.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kexin W, Yaodong D, Wen G, Rui W, Jiaxin Y, Xiaoli L, Hua S, Hailong G. Association of Increased Remnant Cholesterol and the Risk of Coronary Artery Disease: A Retrospective Study. Front Cardiovasc Med 2021;8:740596. [PMID: 34778402 DOI: 10.3389/fcvm.2021.740596] [Reference Citation Analysis]
12 Rabizadeh S, Rajab A, Mechanick JI, Moosaie F, Rahimi Y, Nakhjavani M, Esteghamati A. LDL/apo B ratio predict coronary heart disease in Type 2 diabetes independent of ASCVD risk score: A case-cohort study. Nutr Metab Cardiovasc Dis 2021;31:1477-85. [PMID: 33810957 DOI: 10.1016/j.numecd.2021.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Arocha Rodulfo JI. Approach to the cardiometabolic continuum. Narrative description. Clin Investig Arterioscler 2021;33:158-67. [PMID: 33309070 DOI: 10.1016/j.arteri.2020.10.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Joshi D, Jamadarkhana P, Kumbhare S, Singh A, Kotecha J, Bunger D, Shiwalkar A, Mohanan A, Dutt C. Safety, Tolerability, and Pharmacokinetics of a Novel Mitochondrial Modulator, TRC150094, in Overweight and Obese Subjects: A Randomized Phase-I Clinical Trial. Front Pharmacol 2021;12:729424. [PMID: 34603045 DOI: 10.3389/fphar.2021.729424] [Reference Citation Analysis]
15 Fuster V. Editor-in-Chief's Top Picks From 2020. J Am Coll Cardiol 2021;77:937-97. [PMID: 33602476 DOI: 10.1016/j.jacc.2020.12.044] [Reference Citation Analysis]
16 Mechanick JI, Rosenson RS, Pinney SP, Mancini DM, Narula J, Fuster V. Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar. J Am Coll Cardiol 2020;76:2024-35. [PMID: 33092738 DOI: 10.1016/j.jacc.2020.07.069] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
17 Ghaemi F, Firouzabadi FD, Moosaie F, Shadnoush M, Poopak A, Kermanchi J, Abhari SMF, Forouzanfar R, Mansournia MA, Khosravi A, Mohajer B, Ramandi MMA, Nakhjavani M, Esteghamati A. Effects of a Mediterranean diet on the development of diabetic complications: A longitudinal study from the nationwide diabetes report of the National Program for Prevention and Control of Diabetes (NPPCD 2016-2020). Maturitas 2021;153:61-7. [PMID: 34654529 DOI: 10.1016/j.maturitas.2021.08.003] [Reference Citation Analysis]
18 Mesquita ET, Mendes AP, Moura L, Figueiredo Neto JA, Marcondes-Braga FG, Bacal F, Moreira MDCV, Clausell NO. The Challenges of Heart Failure Yesterday, Today and Tomorrow and the 20 Years of DEIC. Arq Bras Cardiol 2021;116:359-62. [PMID: 33656090 DOI: 10.36660/abc.20201200] [Reference Citation Analysis]
19 Kim MJ. Non-alcoholic Fatty Liver Disease, Cardio-metabolic Syndrome and Hypertension: One Concept Fits Multi-systemic Presentations. Korean Circ J 2020;50:706-8. [PMID: 32725977 DOI: 10.4070/kcj.2020.0217] [Reference Citation Analysis]
20 McInerney A, Tirado-Conte G, Rodes-Cabau J, Campelo-Parada F, Tafur Soto JD, Barbanti M, Muñoz-Garcia E, Arif M, Lopez D, Toggweiler S, Veiga G, Pylko A, Sevilla T, Compagnone M, Regueiro A, Serra V, Carnero M, Oteo JF, Rivero F, Barbosa Ribeiro H, Guimaraes L, Matta A, Giraldo Echavarria N, Valvo R, Moccetti F, Muñoz-Garcia AJ, Lopez-Pais J, Garcia Del Blanco B, Campanha Borges DC, Dumont E, Gonzalo N, Criscione E, Dabrowski M, Alfonso F, de la Torre Hernández JM, Cheema AN, Amat-Santos IJ, Saia F, Escaned J, Nombela-Franco L. Impact of Morbid Obesity and Obesity Phenotype on Outcomes After Transcatheter Aortic Valve Replacement. J Am Heart Assoc 2021;10:e019051. [PMID: 34056919 DOI: 10.1161/JAHA.120.019051] [Reference Citation Analysis]
21 Zhang HJ, Tan X, Wang NJ. National trends in insulin resistance and β-cell dysfunction among adults with prediabetes: NHANES 2001-2016. Chronic Dis Transl Med 2021;7:125-34. [PMID: 34136772 DOI: 10.1016/j.cdtm.2020.11.003] [Reference Citation Analysis]
22 Mechanick JI, Marchetti A, Hegazi R, Hamdy O. Diabetes-Specific Nutrition Formulas in the Management of Patients with Diabetes and Cardiometabolic Risk. Nutrients 2020;12:E3616. [PMID: 33255565 DOI: 10.3390/nu12123616] [Reference Citation Analysis]
23 Wohlford GF, Van Tassell BW, Billingsley HE, Kadariya D, Canada JM, Carbone S, Mihalick VL, Bonaventura A, Vecchié A, Chiabrando JG, Bressi E, Thomas G, Ho AC, Marawan AA, Dell M, Trankle CR, Turlington J, Markley R, Abbate A. Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure. J Cardiovasc Pharmacol 2020;77:49-60. [PMID: 33235030 DOI: 10.1097/FJC.0000000000000931] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Hess DA, Verma S, Bhatt D, Bakbak E, Terenzi DC, Puar P, Cosentino F. Vascular repair and regeneration in cardiometabolic diseases. Eur Heart J 2021:ehab758. [PMID: 34849704 DOI: 10.1093/eurheartj/ehab758] [Reference Citation Analysis]
25 Maranhao Neto GA, Pavlovska I, Polcrova A, Mechanick JI, Infante-Garcia MM, Hernandez JP, Araujo MA, Nieto-Martinez R, Gonzalez-Rivas JP. Prediction of Cardiorespiratory Fitness in Czech Adults: Normative Values and Association with Cardiometabolic Health. Int J Environ Res Public Health 2021;18:10251. [PMID: 34639552 DOI: 10.3390/ijerph181910251] [Reference Citation Analysis]
26 Polcrova A, Pavlovska I, Maranhao Neto GA, Kunzova S, Infante-Garcia MM, Medina-Inojosa JR, Lopez-Jimenez F, Mechanick JI, Nieto-Martinez R, Stokin GB, Pikhart H, Gonzalez-Rivas JP. Visceral fat area and cardiometabolic risk: The Kardiovize study. Obes Res Clin Pract 2021;15:368-74. [PMID: 33744224 DOI: 10.1016/j.orcp.2021.03.005] [Reference Citation Analysis]
27 Lee YB, Kim DH, Kim SM, Kim NH, Choi KM, Baik SH, Park YG, Han K, Yoo HJ. Hospitalization for heart failure incidence according to the transition in metabolic health and obesity status: a nationwide population-based study. Cardiovasc Diabetol 2020;19:77. [PMID: 32534576 DOI: 10.1186/s12933-020-01051-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
28 Mechanick JI, Carbone S, Dickerson RN, Hernandez BJD, Hurt RT, Irving SY, Li DY, McCarthy MS, Mogensen KM, Gautier JBO, Patel JJ, Prewitt TE, Rosenthal M, Warren M, Winkler MF, McKeever L; ASPEN COVID-19 Task Force on Nutrition Research. Clinical Nutrition Research and the COVID-19 Pandemic: A Scoping Review of the ASPEN COVID-19 Task Force on Nutrition Research. JPEN J Parenter Enteral Nutr 2021;45:13-31. [PMID: 33094848 DOI: 10.1002/jpen.2036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
29 Garvey WT. Is Obesity/Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second Generation Medications. Endocr Pract 2021:S1530-891X(21)01380-X. [PMID: 34823000 DOI: 10.1016/j.eprac.2021.11.082] [Reference Citation Analysis]
30 Pfaller B, Siu SC, D'Souza R, Wichert-Schmitt B, Kumar Nair GK, Haberer K, Maxwell C, Silversides CK. Impact of Obesity on Outcomes of Pregnancy in Women With Heart Disease. J Am Coll Cardiol 2021;77:1317-26. [PMID: 33706874 DOI: 10.1016/j.jacc.2021.01.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
31 Hu C, Zhang J, Liu J, Liu Y, Gao A, Zhu Y, Zhao Y. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China. Cardiovasc Diabetol 2020;19:116. [PMID: 32703284 DOI: 10.1186/s12933-020-01091-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Nadolsky KZ. COUNTERPOINT: Artificial Sweeteners for Obesity-Better than Sugary Alternatives; Potentially a Solution. Endocr Pract 2021;27:1056-61. [PMID: 34481971 DOI: 10.1016/j.eprac.2021.06.013] [Reference Citation Analysis]
33 Thibonnier M, Esau C, Ghosh S, Wargent E, Stocker C. Metabolic and energetic benefits of microRNA-22 inhibition. BMJ Open Diabetes Res Care 2020;8:e001478. [PMID: 33004402 DOI: 10.1136/bmjdrc-2020-001478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
34 Svinarich JT. The functional medicine approach to atrial fibrillation: can a cure for atrial fibrillation be found in the gut? Curr Opin Cardiol 2021;36:44-50. [PMID: 33264173 DOI: 10.1097/HCO.0000000000000819] [Reference Citation Analysis]
35 González-Rivas JP, Mechanick JI, Ponte C, de Oliveira-Gomes D, Iglesias-Fortes R, Machado L, Duran M, Marulanda MI, Nieto-Martínez R. Impact of the complex humanitarian crisis on the epidemiology of the cardiometabolic risk factors in Venezuela. Clin Investig Arterioscler 2021:S0214-9168(21)00094-2. [PMID: 34315627 DOI: 10.1016/j.arteri.2021.04.002] [Reference Citation Analysis]